Endogenous accumulation of IFN- in IFN- -R -/- mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN- anti-tumor cytotoxicity in vitro and in vivo

By Elaine G Rodrigues   Luiz R Travassos  

Cytokines, Cellular & Molecular Therapy, Vol. 7, Iss. 3, 2002-06 ,pp. : 107-116

Informa Healthcare

Access to resources Recommend Favorite

Recombinant hIFN-α2b-BCG inhibits tumor growth in a mouse model of bladder cancer

By                    

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 183-194

Spandidos Publications

Access to resources Recommend Favorite

CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab

By DiJoseph John   Dougher Maureen   Armellino Douglas   Kalyandrug Lyka   Kunz Arthur   Boghaert Erwin   Hamann Philip   Damle Nitin  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1107-1117

Springer Publishing Company

Access to resources Recommend Favorite

Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma

By Antonini Giovanni   Cox Maria   Montefusco Enrico   Ferrari Antonella   Conte Esmeralda   Morino Stefania   Latino Pamela   Trasimeni Guido   Monarca Bruno  

Journal of Neuro-Oncology, Vol. 81, Iss. 2, 2007-01 ,pp. : 197-199

Springer Publishing Company

Access to resources Recommend Favorite

Effect of siRNALivin on drug resistance to chemotherapy in glioma U251 cells and CD133+ stem cells

By Liu Yang   Guo Qiang   Zhang Hao   Li GenHua   Feng Song   Yu XiZhen   Kong LingSheng   Zhao Lei   Jin Feng  

Experimental and Therapeutic Medicine, Vol. 10, Iss. 4, 2015-10 ,pp. : 1317-1323

Spandidos Publications

Access to resources Recommend Favorite